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Abstract
Introduction: We report the case of a patient diagnosed with a struma ovarii with lymphocytic thyroiditis of her
ectopic thyroid tissue. We believe that this case presents an unusual variation of a struma ovarii and a rare
presentation of subclinical hyperthyroidism.
Case presentation: A 17-year-old Caucasian female patient who had undergone an ovariectomy and been
diagnosed with a struma ovarii was subsequently found to have persistent subclinical hyperthyroidism with a low
radioiodine uptake. Abdominal magnetic resonance imaging and iodine-131 whole body scanning showed no
residue or recurrence and a thyroid ultrasonography was normal. Laboratory and histopathological findings
suggested Hashimoto’s thyroiditis as the cause of the subclinical thyrotoxicosis, which had presumably started at
the ectopic tissue.
Conclusion: Struma ovarii is a rare cause of thyrotoxicosis, and can be difficult to diagnose in the presence of co-
existing thyroid disorders. In patients with a struma ovarii who have not undergone thyroidectomy, there is no
common consensus on management in terms of residue, recurrence or metastasis. Autoimmune thyroiditis must
be kept in mind for a differential diagnosis.
Introduction
A struma ovarii is an unusual type of mature teratoma
consisting of thyroid epithelium. It shows mostly benign
histopathological features of thyroid tissue [1].
Hyperthyroidism develops in approximately 5% to 15%
of patients, mostly due to an adenoma, and rarely due
to follicular carcinoma [2]. However autoimmune thyr-
oiditis with a struma ovarii has been described in a few
case reports. A struma ovarii generally presents with
non-specific symptoms that are similar to those of other
ovarian neoplasms. Diagnosis is difficult unless the
tumor is very large or causes remarkable thyrotoxicosis.
Radioiodine (I-131) imaging and thyroid uptake studies
are important for the differential diagnosis of thyrotoxi-
cosis, which can be difficult when a struma ovarii is also
present [3]. The appropriate follow-up of patients with a
struma ovarii in terms of residue, recurrence or metasta-
sis after surgical resection is a current topic of debate,
especially for patients with co-existing thyroid disorders.
Here, we report a patient who underwent an ovariect-
omy and was diagnosed with a struma ovarii, and subse-
quently was found to have persistent subclinical
hyperthyroidism as a manifestation of Hashimoto’s
thyroiditis.
Case presentation
A 17-year-old Caucasian female patient had presented at
an emergency department with acute abdominal pain.
Abdominal ultrasonography revealed a hyperdense cystic
mass measuring 20 cm in diameter which included solid
components located on the right side and extending to
the umbilical level, which was confirmed by abdominal
computed tomography (CT). At that time, she under-
went emergency abdominal surgery, in which torsion of
her right ovary, and the mass arising from it, was seen.
A frozen section indicated benign tissue, and the opera-
tion was completed with the removal of a 1600-g
tumoral mass and a salpingo-oophorectomy on the
right. A postoperative pathologic examination had
revealed a benign cystic struma ovarii, confirmed by
immunohistochemical staining for thyroglobulin. The
specimen was remarkable for lymphocytes and lymphoid
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were consistent with lymphocytic thyroiditis (Figure 1).
Thyroid function tests, which had been performed after
the urgent operation, revealed subclinical hyperthyroid-
ism (Table 1).
Two months after surgery, the woman was referred to
our clinic with persistent subclinical hyperthyroidism. A
thyroid ultrasound, scintigraphic imaging of her thyroid
gland with Tc-99 m pertechnetate and iodine-131 whole
body scanning were performed. The thyroid ultrasound
demonstrated a normal thyroid gland in size and mildly
heterogenic parenchymal echogenicity. Functioning
ectopic thyroid tissue was not seen in her inguinal or
pelvic sections in the whole body scan, but condensed
accumulation was observed in her thyroid region, as
expected. The thyroid scintigraphy showed condensed
focal accumulation in the left thyroid lobe, while other
sides of the left lobe remained mildly suppressed and
the right lobe was homogenous. Autoimmune thyroiditis
was thought to be responsible for this focal condensa-
tion; this supposition was later supported by laboratory
investigations, which showed elevated levels of serum
antithyroglobulin (465.7 IU/mL; normal range, 5 U/mL
to 60 U/ml) and antithyroid peroxidase (565.3 IU/mL;
normal range, 10 IU/mL to 115 IU/ml), measured by
electrochemiluminescence immunoassay with a com-
mercially available kit (Immulite 2000, Bio DPC, Los
Angeles, CA, USA). A radioiodine uptake test was per-
formed with 20 mCi I-131 and the results revealed a
decreased uptake, by 16% after four hours, and 27%
after 24 hours. This result showed that the thyroid
gland was also affected, which decreased the iodine
uptake, presumably due to the autoimmune thyroiditis
that originated within the ectopic thyroid tissue. Because
our patient had been symptomatic for one month, she
was started on propylthiouracil (PTU), after confirming
the absence of any residue or recurrence with abdominal
magnetic resonance imaging. After one month of treat-
ment her serum thyroid stimulating hormone level nor-
malized and her thyroid antibody levels decreased, and
so PTU was stopped.
Discussion
Struma ovarii comprise approximately 1% of all ovarian
tumors and 2% to 5% of all ovarian teratomas. They are
composed of mature thyroid tissue -which mostly
(approximately 95%) has a benign nature- occupying
more than 50% of the mass [1]. Thyroid tissue in the
teratoma can exhibit all histological and pathological
patterns of normal thyroid epithelium, such as an ade-
noma or as papillary or follicular carcinoma. It may also
organize in solid, embryonal or pseudotubular patterns
[3]. Immunohistochemical staining for thyroglobulin
may be required to identify the cells’ origin. Thyrotoxi-
cosis originating from a struma ovarii is a rare condition
seen in 5% to 10% of patients, mostly resulting from
adenomas and papillary carcinomas [2]. Some investiga-
tors reported autoimmune thyroiditis (Graves’ disease)
of struma ovarii to be the cause of thyrotoxicosis. Teale
and colleagues demonstrated the presence of thyrotro-
pin receptors on a struma ovarii in a patient with co-
existing Graves’ disease who had undergone remission
after removal of her ovary [4]. They suggested that cir-
culating thyrotropin receptor antibodies could stimulate
the tumor and cause thyrotoxicosis, confirming a case
reported by Kung et al. [5]. There are other case reports
detailing the co-existence of Graves’ disease and struma
ovarii in thyrotoxic patients, however Hashimoto’s thyr-
oiditis of a struma ovarii was described in only a few
case reports. Morrissey speculated that a struma ovarii
resulted in antithyroidal antibody formation and thus
might have caused secondary thyroiditis in a patient
with thyrotoxicosis, who had become euthyroid after
surgery [6]. Bonadio presented the case of a patient with
Hashimoto’s thyroiditis in a struma ovarii, diagnosed
due to the presence of antithyroid antibodies in the
absence of any symptoms and signs of thyroid disease
[7]. Doldi et al. reported another patient diagnosed with
Hashimoto’s thyroiditis in a malignant struma ovarii
based on positive antimicrosomal and antithyroglobulin
antibodies [8]. On the other hand, benign thyroid tissue,
which can spread to the peritoneal cavity (peritoneal
strumosis), has been reported to cause thyrotoxicosis in
ap a t i e n tw i t has t r u m ao v a r i i .W ed i a g n o s e d
Figure 1 Struma ovarii (hematoxylin and eosin stain ×100). (A)
Thyroid follicles surrounded by lymphocytes; (B) strumal
component; (C) adipocyte.
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based on the presence of antithyroid antibodies, but also
confirmed by the histopathologic examination. Although
our patient had neither history of a thyroidal disease
nor related symptoms before, we cannot speculate that
thyroiditis in the struma ovarii had first started the clini-
cal progress, unlike in the case described by Morrissey.
Besides, we do not know the status of her thyroid func-
tion and antibodies prior to surgery. Symptoms related
to thyroiditis became overt within two months of her
surgery, possibly triggered by the administration of the
contrast agent for tomography. Struma ovarii can be
suspected in women with thyrotoxicosis but who do not
have a goiter and who have minimal or absent thyroid
uptake of radioiodine. However, struma ovarii are rare
among other more likely causes of these findings, such
as exogenous thyroid hormone administration and thyr-
o i d i t i s .T h ed i a g n o s i sc a nb em a d eb yr a d i o i o d i n ei m a -
ging of the pelvis through whole body scanning, which
would show the increased accumulation in the ovary [3].
Increased thyroglobulin levels can support a diagnosis of
struma ovarii if antithyroglobulin antibodies are absent.
The serum thyroxin and triiodothyronine ratio and a
low thyroglobulin level can be considered in thyrotoxi-
cosis of exogenous intake. Postoperative I-131 total
body scanning and serum thyroglobulin monitoring is
recommended for the management and follow-up of
patients with malignant struma ovarii for residue, recur-
rence or metastasis. However, the sensitivity of I-131
scanning is very low for the detection of residual or
recurrent malignant tissue, even after total ablation of
the thyroid gland [9]. Besides, thyroglobulin cannot be
considered as a tumor marker in patients whose thyroid
gland has not been totally ablated and/or who are posi-
tive for the antithyroglobulin antibody. Therefore, most
authors recommend the removal of the thyroid gland
for follow-up of patients with a malignant struma [10].
Metastasis is not characteristic for benign struma ovarii
but recurrence is a rare condition. Our patient’s
persistent thyrotoxicosis alerted us firstly to look for a
residue and then for recurrence, maybe on the other
ovary because of the normal appearance of her thyroid
gland. Whole body scanning was not a reliable diagnos-
tic test because she had a functioning thyroid gland, nor
was her thyroglobulin level because of antithyroglobulin
positivity. Besides, we found thyroiditis in a struma
ovarii. A thyroidectomy was not considered given her
young age. We performed abdominal magnetic reso-
nance imaging and ultrasound to exclude residue or
recurrence.
Conclusion
We present the case of this patient because we found
Hashimoto’s thyroiditis in struma ovarii and we wanted
to emphasize the difficulties in management of this rare
condition. There is a paucity of data in the past litera-
ture regarding the optimal follow-up modality for such
patients; our findings may be auxiliary to other
clinicians.
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Table 1 Laboratory findings and thyroid ultrasonographic features of the patient
Normal range Time after surgery
Three days Two months Six months One year
TSH (mIU/mL) 0.27-4.2 0.001 0.004 0.28 2.87
free-T4 (ng/dL) 0.74-1.52 1.32 1.16 0.86 1.42
free-T3 (pg/mL) 2.3-4.2 3.6 3.2 3.1 3.68
Anti-TPO (IU/mL) 10-115 - 565.3 468.2 286.7
Anti-TG (U/mL) 5-60 - 465.7 350.6 139.5
Thyroid volume
a (mm
3) - - 9905.62 9855.41 9818.8
Isthmus thickness (mm) - - 3.2 3.3 3.2
Parenchymal echogenicity - - Mildly reduced Mildly reduced Mildly reduced
aThyroid volume = (right lobe (a×b×c) ml ×0.502) + (left lobe (a×b×c) ml ×0.502)/2
Anti-TG: antithyroglobulin; anti-TPO: antithyroid peroxidase; fT3: free triiodothyronine; fT4: free thyroxine; TSH: thyroid stimulating hormone.
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